One year on after the pandemic started, a vast disparity in access to lifesaving COVID-19 medical tools has opened up between high-income countries and low- and middle-income countries.
A scarcity of medical supplies has been created by the current system of production and supply built on monopolies and industry control over technology and knowledge.
We need to do things differently. The proposed World Trade Organization (WTO) waiver on intellectual property (IP) - co-sponsored by 60 WTO members - offers a pathway out of this pandemic that could help ensure equitable and affordable access to vaccines, treatments and tests.
We invite you to join the High-Level Dialogue on this TRIPS waiver proposal that we are co-hosting to hear directly from leading advocates. They will cover the rationale behind the waiver, the current status of discussions at the WTO, and the opposition the proposal faces from a handful of powerful countries.
Join us tomorrow on Tuesday 4th May at 15:30 CEST